Embecta (EMBC) P/E (2022 - 2026)
Embecta (EMBC) P/E from Apr 1, 2022 to Jun 3, 2026. The TTM Embecta (EMBC) P/E is 1.74. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Embecta (EMBC)
| Year | P/E | Change |
|---|---|---|
| 2026 | 1.74 | -65.13% |
| 2025 | 5.00 | -67.13% |
| 2024 | 15.20 | -1.25% |
| 2023 | 15.40 | +136.70% |
| 2022 | 6.50 | N/A |
Comparison Embecta (EMBC) P/E with competitors
Embecta (EMBC) P/E is 1.74.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -87.15% |
| SOLV | Solventum Corp | 9.19 | +427.44% |
| ZJYL | Jin Medical International Ltd | 14.31 | +721.03% |
| PDEX | Pro-Dex Inc (co) | 17.38 | +897.51% |
| UTMD | Utah Medical Products Inc | 19.32 | +1008.70% |
| ATR | Aptargroup Inc | 19.33 | +1009.29% |
| RMD | Resmed Inc | 19.77 | +1034.30% |
| MMSI | Merit Medical Systems Inc | 26.66 | +1429.84% |
| ALGN | Align Technology Inc | 27.22 | +1461.96% |
| COO | Cooper Companies Inc | 29.86 | +1613.31% |
| STVN | Stevanato Group Spa | 29.88 | +1614.70% |
| HOLX | Hologic Inc | 30.86 | +1671.07% |
| LMAT | Lemaitre Vascular Inc | 34.86 | +1900.27% |
| ALC | Alcon Inc | 40.20 | +2206.79% |
| WST | West Pharmaceutical Services Inc | 41.29 | +2269.61% |
| BDX | Becton Dickinson & Company | 44.61 | +2459.73% |
| NEPH | Nephros Inc | 49.38 | +2733.47% |
| ISRG | Intuitive Surgical Inc | 49.96 | +2766.73% |
| NVST | Envista Holdings Corp | 56.43 | +3138.27% |
| BAX | Baxter International Inc | 63.44 | +3540.31% |
| ICUI | ICU Medical Inc | 74.28 | +4162.69% |
| RGEN | Repligen Corp | 123.98 | +7014.08% |
| NNNN | Anbio Biotechnology - Class A | 223.63 | +12732.59% |
| WRBY | Warby Parker Inc - Class A | 292.87 | +16705.56% |